Main > ONCOLOGY (**) > Leukemia>Lymphocytic>Chronic>R *** > Treatment > Co: USA. G. Brand Idelalisib Tab.+>

---

Co: USA. G. Brand Idelalisib Tab.+>'s subsections
(*) USA>Approval Date: 2014. 07.23
+RituxiMAb>
>Comes Back>Prior Treat.
Company
Mechanism: PI3K Inhibition
Patent>Assignee; Claims; No.; Etc.
TradeMark
TradeMark Web-Site

Co: USA. G. Brand Idelalisib Tab.+>'s products
This section has no products